Table 4 Summary of Concurrent Disease with Incidence ≧ 5%
From: Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
System | Overall (N = 480) | ITT (N = 426) |
|---|---|---|
Psychiatric | 364 (75.83%) | 329 (77.23%) |
Gastrointestinal | 156 (32.50%) | 145 (34.04%) |
Neurological | 114 (23.75%) | 104 (24.41%) |
Cardiovascular | 77 (16.04%) | 74 (17.37%) |
Endocrine | 71 (14.79%) | 62 (14.55%) |
Respiratory | 34 (7.08%) | 31 (7.28%) |
Ears, Nose, Throat | 29 (6.04%) | 28 (6.57%) |
Musculoskeletal | 32 (6.67%) | 31 (7.28%) |